InvestorsHub Logo
Followers 25
Posts 4797
Boards Moderated 0
Alias Born 07/18/2006

Re: F1ash post# 141848

Tuesday, 02/20/2018 2:46:59 PM

Tuesday, February 20, 2018 2:46:59 PM

Post# of 459970
Why does Anavex need to in-license another compound? They already have an laughingly large pipeline that would rival many top-tier pharma companies. But unlike top-tier pharma companies, this company is a one-man band run by a guy who spent 7 years prior to AVXL with a small investment bank (Brimberg & Co) that was expelled from the securities industry by FINRA in May 2013. TGD has a finance background, no prior experience as a CEO and no experience running multiple clinical trials in multiple indications. There is no breadth of capabilities in this senior management team because this is a team of one. If AVXL in-licenses another compound, I would interpret that as a signal that the current crop of drug candidates is a bust.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News